1-(3-Bromophenyl)-1,3-dihydro-2H-imidazol-2-one

Catalog No.: 
ACFUQU757
CAS No.: 
944709-54-0
Molecular Formula: 
C9H7BrN2O
Molecular Weight: 
239.07
1-(3-Bromophenyl)-1,3-dihydro-2H-imidazol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$220.00InquiryInquiry
1g97%$891.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Bromophenyl)-1,3-dihydro-2H-imidazol-2-one
IUPAC Name1-(3-bromophenyl)-1,3-dihydro-2H-imidazol-2-one
Molecular FormulaC9H7BrN2O
Molecular Weight239.07
SMILESO=C1NC=CN1C2=CC=CC(Br)=C2
InChI KeyGSEFYTRZEWBZFT-UHFFFAOYSA-N
Synonym1-(3-Bromo-phenyl)-1,3-dihydro-imidazol-2-one;1-(3-bromophenyl)-1,3-dihydro-2H-imidazol-2-one;2H-Imidazol-2-one, 1-(3-bromophenyl)-1,3-dihydro-;1-(3-Bromophenyl)-2,3-dihydro-1H-imidazol-2-one
CAS No.944709-54-0

Synthetic Route by SureRoute

1. ACFUQU757 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACVWXM149 route compound structure diagram
    ACVWXM14923138-55-8In Stock
  6. Then
  7. ACFUQU757 route product structure diagram
    ACFUQU757944709-54-0
Inquiry

2. ACFUQU757 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQIZU029 route compound structure diagram
    ACQIZU029591-18-4In Stock
  2. Plus
  3. ACHSXP167 route compound structure diagram
    ACHSXP1675918-93-4In Stock
  4. Then
  5. ACFUQU757 route product structure diagram
    ACFUQU757944709-54-0
Inquiry

3. ACFUQU757 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFUQU757 route product structure diagram
    ACFUQU757944709-54-0
Inquiry

Comments (0)